Circassia brings biotech craze from US to London
Circassia launched the first large biotechnology IPO in London on Thursday after a run of listings from the sector in the US. The UK company, which hopes to find a cure for cat allergies, is set to raise £175m through the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts